< Back to scientific publications

Magazine

Use of Plerixafor in Predicted and ProvenPoorMobilizer( according to GITMO criteria). Experience of Tor Vergata University Polyclinic.

Authors: Massimiliano Postorino, Alessandro Lanti, Eleonora Florelli, Angelo Salvatore Ferraro, Oana Marilena Chiuru,Raffaella Massarelli, Luca Franceschini, Giorgia Guiducci,Provenzano I., Livio Pupo, Anna Giulia Zizzari, GaspareAdorno, Maria Cantonetti, Giancarlo Isacchi and Sergio Amadori. (2012).

Date: 2012

Scope of interest: Hematology/Transfusion Medicine




You may also be interested in:

Magazine 15.26

ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease.

Authors: Montecchiani C, Pedace L, Lo Giudice T, Casella A, Mearini M, Gaudiello F, Pedroso JL, Terracciano C, Caltagirone C, et al

Date: 2016

Scope of interest: Neurogenetics


Read details
Magazine 6,089

Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid-19.

Authors:

Date: 2020

Scope of interest: Neurology/emergency


Read details
Report/Poster of Convention/Congress Act

CORONAVIRUS COVID-19: prevention, management, care, mental health and responsibility of the healthcare professional.

Authors: ilaria uccella

Date: 2020

Scope of interest: infectious disease training programs


Read details